Our platform technology consists of mainly two materials which have the following properties:

Shear Thinning

Inverse Thermal Gelling

Our hydrogel provides a sustained therapeutic release which out-competes other available technologies.

AmacaThera

Redefining How Therapeutics Are Delivered

Get to know us better

OUR SERVICES

About Us

AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.

Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.

We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.

Currently, we have developed a combination product for post-operative pain, which is our company's lead project.